Japan - Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases
Since 2014, Japan Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases jumped by 0.5% year on year. In 2019, the country was number 152 comparing other countries in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases at 83 Cases. India lead the ranking with 66,255 Cases in 2019, a growth of 13.6% versus 2018. India, Russia and Russia respectively ranked number 2, 3 and 4 in this ranking. Republic of the Congo recorded the best 5 years average growth at +171.1% per year, while Croatia recorded the worst performance at -100% per year.
Loading...
Date | Units (Cases) |
---|---|
2019 | 83.00 |
2018 | 83.00 |
2017 | 86.00 |
2016 | 79.00 |
2015 | 78.00 |
Download all data from 2007 to 2019
How does Japan rank in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases?
# | 359 Countries | Units (Cases) | Last | YoY | 5‑years CAGR | ||
---|---|---|---|---|---|---|---|
1 |
#1
India
|
66,255 | 2019 | +13.6 % | +20.8 % | View data | |
3 |
#3
Russia
|
29,181 | 2019 | +5.0 % | +13.4 % | View data | |
150 |
#150
Botswana
|
84 | 2019 | -1.2 % | +15.4 % | View data | |
152 |
#152
Japan
|
83 | 2019 | +0.0 % | +0.5 % | View data | |
153 |
#153
Venezuela
|
80 | 2019 | +5.3 % | +25.2 % | View data |